Page last updated: 2024-10-24

carteolol and Chronic Kidney Diseases

carteolol has been researched along with Chronic Kidney Diseases in 1 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Research Excerpts

ExcerptRelevanceReference
" We herein report an elderly patient with CKD who suffered bradycardia shock after the combined use of carteolol eye drops and verapamil for glaucoma and paroxysmal AF."8.02Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease. ( Akutsu, N; Arai, R; Fukamachi, D; Monden, M; Murata, N; Okumura, Y, 2021)
" We herein report an elderly patient with CKD who suffered bradycardia shock after the combined use of carteolol eye drops and verapamil for glaucoma and paroxysmal AF."4.02Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease. ( Akutsu, N; Arai, R; Fukamachi, D; Monden, M; Murata, N; Okumura, Y, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arai, R1
Fukamachi, D1
Monden, M1
Akutsu, N1
Murata, N1
Okumura, Y1

Other Studies

1 other study available for carteolol and Chronic Kidney Diseases

ArticleYear
Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
    Internal medicine (Tokyo, Japan), 2021, Jan-01, Volume: 60, Issue:1

    Topics: Aged; Atrial Fibrillation; Bradycardia; Carteolol; Humans; Japan; Ophthalmic Solutions; Renal Insuff

2021